Stay updated on Ad26.COV2.S Vaccine Study Clinical Trial
Sign up to get notified when there's something new on the Ad26.COV2.S Vaccine Study Clinical Trial page.

Latest updates to the Ad26.COV2.S Vaccine Study Clinical Trial page
- ChecktodayChange DetectedThe page now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedLocations section updated to list state-by-state sites (AL, AZ, AR, CA, CO, FL, GA, IL, IN, KS, KY, LA, MD, MA, MI, MN, MS, MO, NV, NJ, NM, NY, NC, OH, OR, PA, SC, TN, TX, UT, WA); the HHS Vulnerability Disclosure link was removed and the page revision is shown as v3.3.3.SummaryDifference1%

- Check50 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not reflect the study, and the revision version is updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check57 days agoChange DetectedDeleted the funding-lapse notice/banner that warned data on the site may not be up to date.SummaryDifference0.1%

- Check72 days agoChange DetectedThe study record shows no modification to core details; the updates appear to be cosmetic in nature (visual/layout tweaks and timestamp changes). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check79 days agoChange DetectedAdded two new study locations in Cali, Colombia (postal codes 760001 and 760032) and removed the previous entry for Santiago de Cali with the same postal codes from the Locations section.SummaryDifference0.3%

Stay in the know with updates to Ad26.COV2.S Vaccine Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ad26.COV2.S Vaccine Study Clinical Trial page.